Book a demo
Book a live 1:1 demo with one of our expert.
Trusted by 200+ Clients Worldwide
7 500+ Clinical Trials
Simplified Clinical Trial Management
100% Compliant and Secure Solution
A Complete and Agile Platform
“We chose Datacapt for one main reason: it is a complete platform.” - Yolande Varin, Clinial Trial Manager
Dermatech is a company of the Complige Group that offers clinical and instrumental tests (skin biometrology) while researching innovative and relevant methodologies for the evaluation of cosmetic products and medical devices (instrumental or topical)
Can you tell us more about the clinical trials you have conducted with Datacapt?
We have conducted various studies with the Datacapt solution.
We chose Datacapt for one main reason: it is a complete platform. It has a single interface for all accesses with several integrated and innovative modules: eCRF, ePRO and eConsent.
We were already used to working with an eCRF, but we received quality support when we changed service providers. The Datacapt team trained us in only 3 hours to master the solution and was very responsive to all our questions and needs. The implementation of the tool and the learning curve were very quick.
What we like best about the Datacapt platform is the ease of deployment of ePRO (voluntary questionnaires). This allows us to save a considerable amount of time in our studies, while avoiding manual input and the logistics of paper forms. The voluntary feedback is also very positive about the use of an intuitive digital solution for the collection of questionnaire data.
Finally, Datacapt offers a 100% secure solution (21 CFR PART 11, RGPD, ISO 27001), with advanced access management. All data is protected (HDS hosting) and available at any time on different media.
Datacapt is a constantly evolving solution. With each new version, many improvements are made. Remarks are taken into account as well as the few specific requests we may have had.
Datacapt’s advantage is their availability and responsiveness. When questions or problems arise, we are sure to get a quick response from them.